bioQuad and Pro-Vital team up to launch novel health supplements in the Netherlands

Amsterdam, March 6, 2018: bioQuad Europe BV and Pro-Vital have entered a landmark business collaboration in the Netherlands. Pro-Vital will carry Lactoferrin Gold 1.8® and OsteoDenx® as their flagship products for nation-wide distribution in the Dutch health market. Started in 2008, Pro-Vital has emerged as a leading distributor of high quality, natural supplements to physicians, therapists and pharmacists; Pro-Vital works with prominent health professionals and several medical centers throughout Europe.


"Self-healing process can be achieved through innate biological molecules such as ‘lactoferrin’ and bio-active nutraceuticals from the Nature”


“At Pro-Vital we believe in the self-healing ability of the human body. Self-healing process can be achieved through innate biological molecules such as ‘lactoferrin’ and bio-active nutraceuticals from the Nature,” said Dr. Dick Nicolai, a renowned physician from the Medical Centre for Natural Health (MCNA) in Heerenveen, The Netherlands.

Dr. Nicolai added, “We have evaluated the health benefits of bioQuad technologies in several clinics and observed excellent results. Therefore, including Lactoferrin Gold 1.8® and OsteoDenx® to the Pro-Vital product portfolio was an obvious decision.”


"bioQuad OsteoDenx® elicits such outstanding positive effects on bone and joint health that we decided to substitute our existing bone-joint supplement with OsteoDenx®”


During the interview, Mr. Pieter Pieters, Managing Director of Pro-Vital said, “We only use all-natural, active ingredients in our supplements, which meet the highest quality standards, strictly follow EFSA regulations and adhere to the Dutch legislation.” Mr. Pieters further commented, “Our nutritional supplements are functionally designed proprietary formulations, exclusively prescribed through qualified doctors and therapists.” Pro-Vital has earned its reputation as national distributor of therapeutics and functional supplements to several Dutch medical centers.

“I believe that the collaboration between Pro-Vital and bioQuad will initiate a new paradigm shift among health practitioners in Natural Medicine,” shared Mr. Pieters. “The scientific expertise of bioQuad is highly advanced and their health technologies are cutting-edge. For instance, bioQuad OsteoDenx® elicits such outstanding positive effects on bone and joint health that we decided to substitute our existing bone-joint supplement with OsteoDenx®.”


"In a short span of six months bioQuad has established distribution networks in 11 countries and by the end of year 2018, we plan to expand our business operations into 20+ countries spanning Europe and Asia”


“Pro-Vital has a holistic approach to health, which is in alignment with our ongoing global healthcare projects,” said Dr. Sreus Naidu, Managing Director of bioQuad Europe. “We are excited about our collaboration; we have jointly planned for several workshops and symposia in the Netherlands to educate health professionals about our research.” Dr. Naidu continued, “In a short span of six months bioQuad has established distribution networks in 11 countries and by the end of year 2018, we plan to expand our business operations into 20+ countries spanning Europe and Asia.”

bioQuad opened its EU offices in the prestigious University of Amsterdam Science Park, last year. With scientific credibility that span over 35+ years of cutting-edge research, multiple core patents and backed by controlled human clinical studies which are published in peer-reviewed medical journals, bioQuad received immense support from health professionals from major universities, research institutes, hospitals and pharmaceutical companies worldwide.

For more information about this press release, please contact bioQuad at media@bio-quad.com